Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/1471-2261-15-7 http://scihub22266oqcxt.onion/10.1186/1471-2261-15-7 C4407327!4407327!25618133     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25618133&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25618133.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       BMC+Cardiovasc+Disord 2015 ; 15 (ä): ä Nephropedia Template TP {{tp|p=25618133|t=2015. Noncompaction cardiomyopathy: a substrate for a thromboembolic event |pdf=|usr=}}{{25618133}} gab.com Text Noncompaction cardiomyopathy: a substrate for a thromboembolic event JO: BMC Cardiovasc Disord http://www.kidney.de/pget.php?&tw=1&pmid=25618133 #FOAvip Background: Noncompaction cardiomyopathy (NCC) is a rare genetic cardiomyopathy characterized by a thin, compacted epicardial layer and an extensive noncompacted endocardial layer. The clinical manifestations of this disease include ventricular arrhythmia, heart failure, and systemic thromboembolism. Case presentation: A 43-year-old male was anticoagulated by pulmonary thromboembolism for 1 year when he developed progressive dyspnea. Cardiovascular magnetic resonance imaging showed severe biventricular trabeculation with an ejection fraction of 15%, ratio of maximum noncompacted/compacted diastolic myocardial thickness of 3.2 and the presence of exuberant biventricular apical thrombus. Conclusion: Still under discussion is the issue of which patients and when they should be anticoagulated. It is generally recommended to those presenting ventricular systolic dysfunction, antecedent of systemic embolism, presence of cardiac thrombus and atrial fibrillation. In clinical practice the patients with NCC and ventricular dysfunction have been given oral anticoagulation, although there are no clinical trials showing the real safety and benefit of this treatment. Electronic supplementary material: The online version of this article (doi:10.1186/1471-2261-15-7) contains supplementary material, which is available to authorized users. Twit Text FOAVip Noncompaction cardiomyopathy: a substrate for a thromboembolic event ????BMC Cardiovasc Disord http://www.kidney.de/pget.php?&tw=1&pmid=25618133 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25618133 #FOAvip English Wikipedia <ref>{{Cite pmid|25618133}}</ref> Noncompaction cardiomyopathy: a substrate for a thromboembolic event #MMPMID25618133 Tavares de Melo MD; Araújo Filho JABd; Parga Filho JR; de Lima CR; Mady C; Kalil-Filho R; Salemi VMC BMC Cardiovasc Disord 2015[]; 15 (ä): ä PMID25618133show ga Background: Noncompaction cardiomyopathy (NCC) is a rare genetic cardiomyopathy characterized by a thin, compacted epicardial layer and an extensive noncompacted endocardial layer. The clinical manifestations of this disease include ventricular arrhythmia, heart failure, and systemic thromboembolism. Case presentation: A 43-year-old male was anticoagulated by pulmonary thromboembolism for 1 year when he developed progressive dyspnea. Cardiovascular magnetic resonance imaging showed severe biventricular trabeculation with an ejection fraction of 15%, ratio of maximum noncompacted/compacted diastolic myocardial thickness of 3.2 and the presence of exuberant biventricular apical thrombus. Conclusion: Still under discussion is the issue of which patients and when they should be anticoagulated. It is generally recommended to those presenting ventricular systolic dysfunction, antecedent of systemic embolism, presence of cardiac thrombus and atrial fibrillation. In clinical practice the patients with NCC and ventricular dysfunction have been given oral anticoagulation, although there are no clinical trials showing the real safety and benefit of this treatment. Electronic supplementary material: The online version of this article (doi:10.1186/1471-2261-15-7) contains supplementary material, which is available to authorized users. äNoncompaction cardiomyopathy: a substrate for a thromboembolic event (epmc).pdf DeepDyve Pubget Overpricing